Insider sale
ASTRAZENECA PLC
$3.62M
52.18K shares
SARIN ARADHANA plans to sell 52.18K shares of ASTRAZENECA PLC valued at approximately $3.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
19,470 of the securities to be sold were obtained pursuant to the issuer's long-term incentive plan
Long-term incentive plan; securities received from the issuer
50,806 securities to be sold were obtained at completion of the merger between Alexion Pharmaceuticals, Inc and AstraZeneca PLC under the related Form F-4 registration statement
Conversion of shares
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2022 | 19,470 of the securities to be sold were obtained pursuant to the issuer's long-term incentive plan Long-term incentive plan; securities received from the issuer | 121.61K | — |
7/21/2021 | 50,806 securities to be sold were obtained at completion of the merger between Alexion Pharmaceuticals, Inc and AstraZeneca PLC under the related Form F-4 registration statement Conversion of shares | 50.81K | — |
| Total | 172.42K | ||
Units to sell
19.47K
Market value
$1.48M
Units to sell
32.71K
Market value
$2.15M
Units
52.18K
Value
$3.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/5/2023 | 19.47K | $1.48M | Nasdaq | Planned |
11/22/2022 | 32.71K | $2.15M | Nasdaq | Planned |
| Total | 52.18K | $3.62M | ||